|
|
|
|
 |
|
SENSEX
|
 |
-65.35
|
-0.27%
|
|
24570.65
|
|
|
|
NIFTY
|
 |
-455.59
|
-0.58%
|
|
78499.17
|
|
|
|
Nasdaq
|
 |
342.27
|
1.30%
|
|
26690.62
|
|
|
|
Nikkei 225
|
 |
-76.55
|
-0.12%
|
|
65606.71
|
|
|
|
FTSE 100
|
 |
33.20
|
0.31%
|
|
10901.10
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cadila |
|
BSE Code |
532321
|
|
ISIN Demat |
INE010B01027
|
|
Book Value (Rs) |
226.28
|
|
|
NSE Code |
ZYDUSLIFE
|
|
Dividend Yield % |
0.09
|
|
Market Cap (Rs) |
1112416.27
|
|
|
TTM PE(x) |
31.25
|
|
TTM EPS(Rs) |
35.69
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
15-05 1995
|
|
Registered Office
|
Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat-382481 .
|
|
ISINNO
|
INE010B01027
|
|
Phone
|
079-71800000 / 48040000
|
|
E-mail
|
dhavalsoni@zyduscadila.com |
|
URL
|
www.zyduscadila.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Pankaj R Patel
|
|
Managing Director
|
Sharvil P Patel
|
|
Company Secretary
|
Dhaval N Soni
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|